Quick Snapshot: Three Platforms, Three Different Strengths
Hims Weight Loss: Deep Dive
Hims (Hims & Hers Health) — Generalist Scale Model
Hims launched in 2017 as a men's health telehealth platform and grew rapidly into one of the largest direct-to-consumer health companies in the US (NYSE: HIMS). Their weight loss program offers compounded semaglutide through an asynchronous telehealth model: you complete a health questionnaire, a licensed provider reviews it without a live conversation in most plans, and if appropriate, a prescription is issued and filled through a partner compounding pharmacy.
Hims' primary competitive advantage is pricing at the entry level. Starting doses of semaglutide are advertised at $79 to $99/month — the lowest in the market among major platforms. This makes Hims attractive for first-time GLP-1 patients uncertain about committing to long-term treatment. The key limitation is dose-tier pricing: as patients escalate from starting doses to maintenance doses, the monthly rate increases to $149 to $199/month. At maintenance — where patients spend most of their treatment time — Hims' effective cost is comparable to or higher than Luma Health's $197/month flat.
Hims covers dozens of health categories beyond weight loss, which means its providers are generalists rather than weight management specialists. For patients whose primary concern is GLP-1 access at the lowest possible entry price through a recognizable brand, Hims is a legitimate option. For patients planning a full 12+ month treatment course and prioritizing maintenance-dose cost and pharmacy transparency, the comparison changes.
✓ Hims Strengths
- ✓ Lowest advertised entry price ($79–$99/mo)
- ✓ Large publicly traded company — platform stability
- ✓ Polished app experience
- ✓ Multi-condition platform convenience
✗ Hims Limitations
- ✗ Dose-tier price increases at maintenance
- ✗ Generalist model — not GLP-1 specialist
- ✗ Pharmacy not prominently disclosed
- ✗ Some plans require 3–6 month commitment
Ro Body: Deep Dive
Ro Body — Clinical Depth + Integrated Pharmacy Model
Ro (formerly Roman) launched in 2017 with a men's health focus and developed its dedicated weight management division, Ro Body, as GLP-1 medications became mainstream. Ro's differentiator compared to Hims is clinical depth: Ro emphasizes video consultations with providers rather than purely asynchronous questionnaire review, optional metabolic lab work to inform treatment decisions, structured check-ins, and a more engaged clinical relationship throughout the treatment course.
Ro also operates its own integrated pharmacy facilities — a meaningful structural distinction from platforms that outsource to third-party compounders. This integrated pharmacy model provides Ro with more direct quality control over medication preparation and a stronger pathway for insurance coordination for brand-name Wegovy or Zepbound (a genuine Ro differentiator for insured patients pursuing prior authorization). Ro has been operating for 8+ years with $1B+ in institutional backing, providing platform longevity that newer compounded GLP-1 providers cannot match.
Ro's limitations are primarily cost-related: starting at $145–$169/month and reaching $199–$249/month at semaglutide maintenance (and $299–$399/month for tirzepatide at maintenance), Ro is consistently more expensive than both Hims and Luma Health for cash-pay compounded medication.
✓ Ro Strengths
- ✓ Video consultations with providers
- ✓ Optional metabolic lab work
- ✓ Integrated pharmacy (own facilities)
- ✓ 8+ year operating history
- ✓ Insurance nav for brand Wegovy/Zepbound
✗ Ro Limitations
- ✗ Higher price at maintenance than Luma Health
- ✗ Tirz at $299–$399/mo (vs. Luma $297 flat)
- ✗ Generalist multi-condition model
- ✗ Some plans require 3-month commitment
The Pricing Comparison That Actually Matters
The key insight in comparing Hims, Ro, and Luma Health is that starting price and maintenance price are different numbers — and most patients spend 70–80% of their treatment time at maintenance doses, not starting doses.
| Dose Tier | Hims | Ro Body | Luma Health |
|---|---|---|---|
| Starting (0.25 mg/wk sema) | ~$79–$99/mo | ~$145–$169/mo | $197/mo |
| Titration (0.5–1.0 mg/wk) | ~$99–$149/mo | ~$169–$199/mo | $197/mo |
| Maintenance (1.7–2.4 mg/wk) | ~$149–$199/mo | ~$199–$249/mo | $197/mo flat |
| 12-mo total (maint. midpoint) | ~$1,788–$2,388 | ~$2,388–$2,988 | $2,364 |
| Tirz (maintenance) | ~$199–$329/mo | ~$299–$399/mo | $297/mo flat |
At maintenance doses, the pricing picture changes significantly from what the introductory rates suggest. Hims' effective maintenance-dose cost ($149–$199/month) is roughly equivalent to or slightly higher than Luma Health's $197/month flat. Ro's maintenance-dose cost ($199–$249/month for sema, $299–$399/month for tirz) is consistently higher than Luma Health. The price advantage Hims advertises at entry tiers largely disappears by months 3–5 of treatment.
Full Three-Way Feature Comparison
| Factor | Hims | Ro Body | Luma Health |
|---|---|---|---|
| Sema starting price | ~$79/mo | ~$145–$169/mo | $197/mo flat |
| Sema maintenance price | ~$149–$199/mo | ~$199–$249/mo | $197/mo flat |
| Tirz price | ~$199–$329/mo | ~$299–$399/mo | $297/mo flat |
| Dose-tier increases | Yes | Yes | ✓ None |
| Consultation model | Async (questionnaire) | ✓ Video + async | Async (all included) |
| Metabolic lab work | Not standard | ✓ Available | Not included |
| Insurance nav (brand) | Limited | ✓ Wegovy/Zepbound pathway | Cash-pay focus |
| Pharmacy named publicly | Not prominently | Integrated (own facilities) | ✓ VialsRX, TX #35264 |
| Contract required | Some plans (3–6 mo) | Some plans (3 mo) | ✓ None |
| Clinical specialization | Generalist (many conditions) | Multi-condition + weight focus | GLP-1 + metabolic health |
| Platform longevity | ✓ 2017, NYSE listed | ✓ 2017, $1B+ backed | Newer platform |
| Named clinical provider | Not prominently | Ro-employed/contracted | ✓ Wasef Health, PC |
Who Each Platform Is Right For
Choose Hims If...
- ● You want the lowest possible entry price ($79/mo) for your first 1–2 months before committing
- ● You already use Hims for other health needs and want everything on one platform
- ● The publicly traded, well-established brand creates trust for your first GLP-1 experience
- ● You will confirm the maintenance-dose price before enrolling and are comfortable with dose-tier increases
Choose Ro If...
- ● You want video consultations with your provider rather than async questionnaire-only
- ● You are insured and want to pursue brand-name Wegovy or Zepbound through insurance coordination
- ● Metabolic lab work integration in your treatment decisions matters to you
- ● You want the platform stability and operational track record of an 8-year-old company with $1B+ backing
★ Choose Luma Health If...
- ★ You want flat-rate pricing at every dose — $197/mo sema and $297/mo tirz, never changing regardless of dose tier
- ★ Pharmacy transparency matters — VialsRX (TX #35264) publicly named and independently verifiable
- ★ You are a cash-pay patient planning 6+ months of treatment and need cost predictability
- ★ No contracts, no commitment periods, cancel anytime with no penalty
Frequently Asked Questions
Is Hims or Ro better for GLP-1 weight loss?
It depends on what you prioritize. Hims wins on entry-level pricing ($79–$99/month at starting doses) and platform scale. Ro wins on clinical depth — video consultations, optional metabolic labs, and insurance navigation for brand-name GLP-1 — and has the stronger integrated pharmacy model. For cash-pay patients primarily interested in the most predictable all-in cost at maintenance doses, Luma Health's $197/month flat rate is equivalent to Hims' maintenance-dose pricing and lower than Ro's, while offering more pharmacy transparency than either. Neither Hims nor Ro is the universally better answer — the right choice depends on your priorities.
How does Hims pricing compare to Ro at maintenance doses?
At starting doses, Hims is significantly cheaper (~$79/mo vs. Ro's ~$145/mo). At maintenance doses (1.7–2.4 mg/week semaglutide), the gap narrows substantially: Hims reaches $149 to $199/month at maintenance while Ro reaches $199 to $249/month. At those maintenance price ranges, Luma Health's $197/month flat is directly competitive with Hims' upper maintenance tier and lower than Ro's maintenance pricing — without any dose-tier increases. The entry price advantage Hims holds largely disappears by months 3–5 of treatment when most patients reach maintenance doses.
Does Ro offer video consultations for weight loss?
Yes. Ro's Ro Body program includes video consultation options with licensed providers — a meaningful clinical differentiator compared to Hims' primarily asynchronous model. For patients who want real-time conversation about their medical history, goals, side effects, or dose adjustments, Ro's video consultation capability provides a more engaged clinical experience. Hims uses questionnaire-based asynchronous evaluation for most plans. Luma Health uses asynchronous intake reviewed by licensed clinicians through Wasef Health, PC — no video consultations, but all consultations and dose adjustments are included in the flat $197/month rate.
Can Ro help me get insurance coverage for Wegovy or Zepbound?
Yes. Ro's integrated pharmacy model and insurance coordination capability give them a genuine pathway for patients with commercial insurance who want to pursue prior authorization for brand-name Wegovy or Zepbound. For insured patients who receive prior authorization and apply a manufacturer savings card, brand-name medication through Ro can be cost-effective. Hims has more limited insurance coordination for brand-name GLP-1. Luma Health focuses exclusively on cash-pay compounded alternatives and does not navigate insurance for brand-name GLP-1 — but at $197/month flat for compounded semaglutide, no insurance coordination is needed.
Is there a cheaper alternative to both Hims and Ro for GLP-1?
At starting doses, Hims ($79–$99/month) is the cheapest among the three platforms covered here. At maintenance doses — where most treatment time is spent — Luma Health ($197/month flat) is comparable to Hims' upper maintenance tier and cheaper than Ro's maintenance pricing. The specific answer depends on which dose tier you are comparing. For patients who want the same price from day 1 through month 18 regardless of dose, Luma Health's flat rate eliminates all dose-tier price uncertainty that both Hims and Ro carry.
What pharmacy does Hims use for compounded GLP-1?
Hims does not prominently disclose its specific compounding pharmacy partner in public marketing materials. For independent pharmacy verification before enrolling, patients would need to contact Hims directly and request the pharmacy's name and state board license number. Ro uses its own integrated pharmacy facilities. Luma Health publicly names VialsRX (Texas State Board of Pharmacy license #35264), which patients can verify independently at pharmacy.texas.gov before providing any payment information.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed
- FDA. Human Drug Compounding — Section 503A. FDA.gov
- NABP. Compounding Pharmacy Accreditation. nabp.pharmacy
- Hims & Hers Health. Weight Loss Program. hims.com
- Ro Body. Weight Loss Program. ro.co
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov
- FDA. Wegovy Prescribing Information. FDA.gov